Levetiracetam
Product Images NDC 14335-050

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 14335-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hainan Poly Pharm. Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (01)

This is a table showing the percentage of patients on placebo and two different doses of Levetiracetam (1,000 mg/day and 3,000 mg/day). The number of patients in each group is also provided.*

FDA Label Image

Figure 2 (02)

FDA Label Image

Figure 3 (03)

This is a table showing the percentage of patients in two groups: Placebo (N=104) and Levetiracetam 3,000 mg/day (N=180). The percentages range from 0% to 45% in increments of 5%.*

FDA Label Image

Figure 4 (04)

The text represents a graph showing the percentage of patients who participated in a study and received either a placebo or Levetiracetam. The data is presented in a bar graph format with the percentages on the y-axis and the two groups on the x-axis. The placebo group had a percentage of 19.6% while the Levetiracetam group had a percentage of 44.6%.*

FDA Label Image

Figure 5 (05)

FDA Label Image

Figure 6 (06)

This appears to be a table showing the percentage of patients who received either a placebo or levetiracetam in a medical study. The percentage of patients who received levetiracetam is not provided, but the percentage of patients who received the placebo is 45.2%. The number of patients in the placebo group is 84, and the number of patients in the levetiracetam group is 79.*

FDA Label Image

Principal Display Panel (100 mg/mL Vial Carton)

This is a description of a medication called Levetiracetam Injection USP. It is available in a package containing 10 single-dose vials that are 5 mL each, with a strength of 500 mg/5 mL (100 mg/mL). This medication is for intravenous use and must be diluted before administration. It is only available with a prescription and is sterile. The usual dosage and other important information are not available. The medication is made by a company with the NDC number 14335-050-10, and the package contains a lot number and an expiration date.*

FDA Label Image

Chemical Structure (Levetiracetam 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.